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Abstract
We report an unusual patient with primary adenocarcinoma of lung causing malignant pleural and
pericardial effusions. The diagnosis was made only at autopsy as his staging computed tomography
scan of chest was negative for an obvious mass lesion within the lung or pleura. Prior to his death,
his symptoms were erroneously managed as left ventricular failure and community-acquired
pneumonia.
Case Report
A 79 year-old man was admitted with a five-day history of
exertional dyspnoea, cough and dull pain across the lower
chest. There was no history of orthopnoea or paroxysmal
nocturnal dyspnoea. The cough was productive of scanty
white sputum, but there was no haemoptysis. He was
known to have angina pectoris on exertion. Past medical
history included deep vein thrombosis and locally inva-
sive prostate cancer, which had been successfully treated
with radiotherapy ten years ago. Before his current presen-
tation, the patient was independent and mobile, able to
perform most of his activities of daily living unaided.
There was no history of recent weight loss. His regular
medications included atenolol, aspirin, atorvastatin,
perindopril, meloxicam, diazepam, paracetamol, omepra-
zole, and sublingual glyceryl trinitrate spray and a salbuta-
mol metered dose inhaler as needed. He had smoked a
packet of cigarettes daily for just one year in his youth.
On examination, he was afebrile and haemodynamically
stable. He had mild pitting oedema of the ankles. His
chest was clear and cardiovascular examination was nor-
mal. He had mild epigastric tenderness. Arterial blood
gases while breathing room air showed borderline
hypoxia (9.0 kPa). An electrocardiogram exhibited sinus
rhythm with no acute change. Blood tests showed a white
cell count of 10.4 × 109/L (range 4.0-10.0 × 109/L) and a
high C-reactive protein (CRP) of 78 mmol/L (range <7.5
mmol/L). The troponin I was normal (0.03 ng/ml) but the
d-dimer was markedly raised at >1050 ng/ml (range
<255). A postero-anterior chest radiograph showed evi-
dence of cardiomegaly (cardiothoracic ratio 0.58), but
clear lung fields.
The initial differential diagnoses included pulmonary
embolism or left ventricular failure and the patient was
started on subcutaneous therapeutic doses of a low-
molecular weight heparin injection. A computed tomog-
raphy pulmonary angiogram (CTPA) on the following
day showed no evidence of pulmonary embolism, but
there was a significant 3.5 cm pericardial effusion and
bilateral pleural effusion with right basal consolidation
(Figure 1). On the basis of these results, an urgent
echocardiogram was requested. The patient was com-
menced on oral antibiotics. The low molecular weight
heparin injections were discontinued and the patient was
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transferred to the coronary care unit. The patient had an
echocardiogram-guided pericardiocentesis, and 850 ml of
heavily blood stained pericardial fluid was drained.
Serum tumour markers showed an isolated elevation of
Ca19.9 at 454 ku/L (normal range 0-37 ku/L). Pericardial
fluid cytology was interpreted as showing either reactive
mesothelial proliferation or possible metastatic adenocar-
cinoma.
Given the pericardial fluid cytology suggestive of cancer,
and an elevated serum Ca19.9, his CTPA was reviewed
and found to be negative for a mass lesion within the
lungs or pleura. Hence he was further investigated for a
possible primary in the abdomen. A computed tomogra-
phy (CT) scan of his abdomen and pelvis showed no evi-
dence of a mass lesion or lymphadenopathy. A follow-up
echocardiogram revealed a residual small pericardial effu-
sion, with good left ventricular systolic function (esti-
mated left ventricular ejection fraction of 61%). Due to
his frail general condition and exertional dyspnoea, a CT
scan of colon was performed instead of a colonoscopy,
which was also normal. Following drainage of his pericar-
dial effusion his presenting symptoms of dyspnoea, cough
and chest pain improved and he was discharged home
with an upper gastrointestinal endoscopy planned on an
outpatient basis.
He was readmitted a few days later with worsening cough,
dyspnoea, orthopnoea, and mild chest pain. On examina-
tion, he had sinus tachycardia and bilateral pleural effu-
sions and basal chest crackles. Hence, despite a good left
ventricular function on his recent cardiac echo, a provi-
sional diagnosis of left ventricular failure was made. Diu-
retic therapy led to symptomatic improvement and he was
discharged on a maintenance dose of diuretic.
Eight days later he was admitted again with recurrence of
his dyspnoea and productive cough. This time the blood
inflammatory markers were raised and his right-sided
pleural effusion had increased significantly, with associ-
ated right basal lung consolidation (Figure 2). He was
therefore treated for a community-acquired pneumonia.
An ultrasound-guided pleural aspirate and biopsy were
initially reported as showing either a reactive mesothelial
proliferation or metastatic adenocarcinoma. However,
immunohistochemistry being negative for thyroid tran-
scription factor 1 (TTF-1) was more in favour of reactive
mesothelial proliferation. The patient had an intercostal
chest drain for two days and his clinical condition
improved transiently. A week after admission, he died fol-
lowing a cardiac arrest.
An autopsy revealed collapse of both lower lobes. The
right lower lobe contained a 2 cm solid nodule with a
necrotic centre, whilst a 3 × 1 cm nodule was seen within
the left pleura. Small metastatic pericardial and chest wall
tumour deposits were also identified. Autopsy also
revealed a proximal left lower limb deep vein thrombosis,
and the entire pulmonary vasculature was occluded by
pulmonary thromboemboli. A diagnosis of a poorly-dif-
CTPA scan image through lower chest showing bilateral  pleural effusion and a significant pericardial effusion Figure 1
CTPA scan image through lower chest showing bilat-
eral pleural effusion and a significant pericardial effu-
sion.
An AP view chest radiograph showing right-sided pleural  effusion and right basal consolidation Figure 2
An AP view chest radiograph showing right-sided 
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ferentiated metastatic adenocarcinoma of lung was con-
firmed from the specimens taken at autopsy. His
immediate cause of death, however, was pulmonary
embolism complicating the metastatic lung cancer.
After having the autopsy findings, his radiology was
reviewed. Once again, the primary deposit in the right
lung and the metastatic nodule within the left-sided
pleura were not evident on his chest CT scan.
Discussion
Carcinoma of the lung is now the second most common
cancer in the UK (having recently been overtaken by
breast cancer). Statistics reported by Cancer Research UK,
state that the incidence is presently 64.4 cases per 100,000
people per year (a total of 39,027 cases in the UK in
2006)[1,2]. Most patients will present with cough, hae-
moptysis, dyspnoea or chest pain, often with concurrent
weight loss and anorexia and any other symptoms due to
metastases. Majority of patients are current or ex-smokers.
The diagnosis is usually suspected after having an abnor-
mal chest radiograph and confirmed by bronchoscopic or
percutaneous CT-guided biopsies. The extent of cancer
spread is assessed by a staging CT scan of chest and abdo-
men. The information provided by the CT scan is often
supplemented by a positron emission tomography (PET)
scan.
This case describes an interesting presentation of adeno-
carcinoma of the lung, which was diagnosed only post
mortem. The cause of death was pulmonary embolism
secondary to adenocarcinoma of lung, with evidence of
metastatic pleural and pericardial infiltration.
This case presented significant diagnostic difficulties. At
his first hospital admission, lung cancer was not suspected
as he had smoked only one pack year in his youth and
there was no history of weight loss. A known history of
ischaemic heart disease, and the findings of mild pitting
oedema and bilateral pleural effusions led us more
towards a diagnosis of an acute cardiac event causing car-
diac failure. Furthermore, there was no obvious mass
lesion on the chest radiograph, or even the chest CT. The
symptoms of dyspnoea, chest pain and cough experienced
by the patient, were also consistent with other differential
diagnoses such as pulmonary embolism, or lower respira-
tory tract infection. Certainly, on his last hospital admis-
sion, raised levels of inflammatory markers and the
appearance of consolidation on chest CT scan were more
suggestive of an infective process.
On reviewing his radiology after the autopsy, it was felt
that the presence of basal collapse had made the identifi-
cation of the 2 cm right lower lobe malignant pulmonary
nodule on his CT scan virtually impossible. In addition,
the left pleural nodule was also missed on the CT as,
despite being 3 cm in diameter, it was just a centimetre
thick, and it was also contiguous to the large left pleural
effusion.
It is not surprising, therefore, that the correct diagnosis of
metastatic lung cancer could not be made before this
patient's death. There was a possible brief window of
opportunity to perform more invasive diagnostic investi-
gations such as a bronchoscopy or a video-assisted thora-
coscopy (VATS), prior to his discharge at the first
admission. A bronchoscopy, however, may not have
yielded the diagnosis as the right lower lobe tumour was
small and peripheral. A VATS would have first required a
review by our visiting thoracic surgeon followed by a
transfer to the regional thoracic surgical centre. Also, there
were concerns as to his tolerability for a VATS procedure
under general anaesthesia. Hence, on balance, with the
patient improving after the pericardial tap, and his CT
scan showing no obvious pulmonary or pleural mass, dis-
charge from hospital with an early outpatient follow-up
was considered a more reasonable approach.
The finding of elevated Ca 19.9 did raise the suspicion of
a possible underlying intra-abdominal carcinoma. This
led to the CT of abdomen, pelvis and colon, which did not
facilitate the correct diagnosis. Ca 19.9 is usually elevated
in pancreatic cancer. It may also be positive in many other
malignancies including colorectal, gastric, oesophageal,
hepatocellular, pulmonary and ovarian cancers, and in a
number of benign acute and chronic conditions such as
acute cholangitis or pancreatitis and chronic liver dis-
ease[3]. Hence it has poor sensitivity and specificity. In
retrospect, the finding of raised Ca 19.9 was unhelpful
and it simply led to the unnecessary investigation of CT
scan of the abdomen and pelvis.
With the benefit of hindsight, however, there were some
aspects of the case more in keeping with a primary lung
cancer. Firstly, both the pericardial and pleural fluid cytol-
ogy, raised the suspicion of an adenocarcinoma. Sec-
ondly, the abnormalities were primarily in the chest with
haemorrhagic effusions within the pleural and pericardial
spaces, suggesting a primary intra-thoracic malignancy. A
thoracoscopic pleural biopsy may have yielded the diag-
nosis. Unfortunately, the patient was considered too frail
to perform any invasive investigation. Furthermore, his
initial presentation suggesting an acute cardiac event lead-
ing to heart failure, with transient improvement after per-
icadiocentesis, side-tracked the team looking after him.
The immediate cause of death in this patient was the
extensive pulmonary embolism confirmed at autopsy.
This is not surprising as several studies confirm the
increased incidence of venous thrombo-embolism in can-Publish with BioMed Central    and   every 
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cer patients including those with lung cancer. The risk is
particularly high in primary cancers of the pancreas, pros-
tate and the central nervous system, especially during the
first few months after the diagnosis of cancer and in the
presence of distant metastases[4,5]. Apart from cancer-
related factors increasing blood coagulopathy, a number
of other factors including reduced mobility, dehydration,
surgery for the cancer, certain chemotherapeutic agents,
and the use of indwelling central venous catheters for
chemotherapy, also potentiate the risk[4].
With hindsight, we feel that his prognosis would not have
altered by coming to the correct diagnosis before his
death. Except for the potentially treatable terminal event
of extensive pulmonary embolism, and talc pleurodesis
after draining his malignant pleural effusion, there were
no other specific therapies that could have made a differ-
ence. Unfortunately, we missed an opportunity to treat his
pulmonary embolism because of a negative CTPA at his
first admission. As for talc pleurodesis, it could not be
offered without a firm diagnosis of cancer.
In conclusion, this case was an unusual presentation of
adenocarcinoma of lung. The diagnostic difficulties were
caused by his rather non-specific presentation and by the
absence of an obvious pleural or pulmonary mass lesion
on the CT scan. We should always consider lung cancer in
elderly patients presenting with chest symptoms and pleu-
ropericardial effusion even in the absence of a smoking
history or an obvious mass lesion on chest CT scan. Tho-
racoscopy is an important investigation in the diagnosis
of lung cancer in such patients if they are well enough to
tolerate it.
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